MTOR and sarcopenia: In sarcopenia and OA patients, DDIT4/REDD1 modulates mTOR signalling pathways, contributing to muscle protein synthesis and degradation balance, affecting chondrocyte survival and function under stress conditions, thus playing an important role in muscle atrophy and OA.